Global Veterinary Vaccines, 2018: Current Status, Technologies and Trends - ResearchAndMarkets.com

DUBLIN--()--The "Veterinary Vaccines 2018: Current Status, Technologies and Trends" report has been added to ResearchAndMarkets.com's offering.

This report presents a detailed overview of the role of vaccines in the animal health market.

Vaccines continue to lead the animal health market in terms of innovative growth. There has been significant progress in the pig and poultry vaccine sectors in particular. Aquaculture has also seen a substantial rise due to the emergence of novel infectious diseases that require innovative solutions.

Key Insights

  • Current Status
  • Technologies & Trends
  • Markets & Companies
  • Regulations

Companies Mentioned

  • Biogenesis Bago (Argentina)
  • Boehringer Ingelheim (Germany)
  • Ceva (France)
  • China Animal Husbandry (China)
  • Elanco (US)
  • Hester (India)
  • Hipra (Spain)
  • IDT Biologika (Germany)
  • Jinyu Bio-technology (China)
  • Merck Animal Health (US)
  • Phibro Animal Health (US)
  • Tianjin Ringpu (China)
  • Vetoquinol (France)
  • Virbac (France)
  • Zoetis (US)

Topics Covered

Executive Summary

Chapter 1: Veterinary vaccines and the global animal industries

1.1 Introduction

1.2 Where do vaccines fit?

Chapter 2: Global markets and companies

2.1 The animal health market

2.2 The animal health companies

2.3 Examples of territories

2.3.1. Asia

2.3.2. China

2.3.3. Latin America

2.3.4. Middle East Region

2.3.5. Saudi Arabia

Chapter 3: Vaccine development and production

3.1 The response to vaccination

3.2 Immune response to bacterial infection

3.3 Immune response to viral infection

3.4 Immune response to parasitic infection

3.5 Mucosal immunity

Chapter 4: Vaccine Technologies

4.1 Conventional vaccines

4.1.1. Live attenuated (modified live) vaccines

4.1.2. Inactivated vaccines

4.2 Molecular approaches to vaccine development

4.2.1. Vector-based veterinary vaccines

4.2.2. Plant based vaccines

4.2.3. DNA Vaccines

4.2.4. Gene deleted vaccines

4.2.5. DIVA vaccines

4.2.6. Virus Like Particles

4.3 Current issues in vaccine stability

Chapter 5: The use of adjuvants and other carriers to enhance the immune response

5.1 Introduction to adjuvants

5.2 Novel approaches to adjuvants

5.2.1. Bacterial ghosts

5.3 Injection site reactions

5.4 Adjuvant delivery systems

5.4.1. Immune stimulating complexes (ISCOM)

5.4.2. Particle based adjuvants

5.4.3. Polymers synthetic and natural

5.4.4. Liposomes

5.4.5. Virosomes

5.5 Cytokines as immunopotentiators

5.6 Nanoparticles

5.7 Other potential adjuvants

5.8 Laser adjuvants

Chapter 6: Poultry vaccines

Chapter 7: Cattle and small ruminant (sheep and goat) vaccines

7.1 Calf enteric disease

7.2 Bovine respiratory disease (BRD)

7.3 Bovine reproductive vaccines

7.3.1. Bovine Viral Diarrhoea Virus (BVDV)

7.3.2. Brucellosis

7.3.3. Neospora caninum

7.4 Bovine tuberculosis

7.5 Mastitis vaccines

7.6 Tick vaccines

7.7 Other parasite vaccines

7.8 Sheep and Goat Vaccines

7.8.1. Introduction

7.8.2. Clostridial disease

Chapter 8: Pig vaccines

8.1 Enteric disease

8.2 Viral vaccines

8.2.1. Swine influenza

8.2.2. Porcine circovirus

8.2.3. Porcine reproductive and respiratory syndrome (PRRSV)

8.2.4. Porcine epidemic diarrhoea (PED)

Chapter 9: Companion animal vaccines

9.1 Dog vaccines

9.2 Cat vaccines

9.3 Equine vaccines

Chapter 10: Vaccines for aquaculture

10.1 Introduction

10.2 Autogenous vaccines for fish

10.3 Viral vaccines in aquaculture

10.4 Bacterial vaccines in aquaculture

10.5 Fish vaccine administration

10.6 Novel delivery systems for fish vaccines

Chapter 11: Routes of vaccine administration

11.1 Needle free vaccination

11.2 Oral/mucosal route

11.3 Oral administration of vaccines in fish

Chapter 12: International Regulation of veterinary vaccines

Chapter 13: Future outlook

List of Figures

Figure 1: Numbers of dogs in the USA

Figure 2: The global veterinary vaccines market

Figure 3: Drivers of the veterinary vaccine market

Figure 4: Some animal industry statistics published by Vetnosis

Figure 5: The global veterinary vaccine market by technology

Figure 6: U.S. Animal health market, by product class, 2014-2025 (USD Billion)

Figure 7: Sales forecast for veterinary vaccines in India

Figure 8: Veterinary vaccine industry in China

Figure 9: The Saudi Arabia Animal Vaccines Market, 2014-2022 ($Million)

Figure 10: Schematic of the mammalian imune system

Figure 11: Illustration of humoral and cell mediated immune pathways (Google)

Figure 12: The mucosal immune system (Google)

Figure 13: Simplistic overview of the immune system

Figure 14: Rinderpest eradication (Arpexas presentation)

Figure 15: Scheme of recombinant vaccine development strategies

Figure 16: Example of vaccine production from a plant source

Figure 17: Representation of a virus like particle.

Figure 18: Schematic representation of a liposome

Figure 19: Properties of nanoparticles

Figure 20: Schematic representation of adjuvant action in stimulating immune responses

Figure 21: Mechanism of action of laser adjuvant

Figure 22: Common viral pathogens that threaten poultry health.

Figure 23: Announcement of the AgResults/GALVmed Brucella vaccine prize

Figure 24: The ILRI ECF consortium website

List of Tables

Table 1: Landmarks in vaccine technology development over the past 200+ years

Table 2: The largest global animal health companies and their revenue (USD billion)

Table 3: Characteristics of different categories of veterinary vaccines

Table 4: Recombinant veterinary vaccines available in 2017

Table 5: Examples of plant-derived immunogenic veterinary viral antigens tested against disease challenge in target animals

Table 6: Examples of antigen delivery and immunopotentiator adjuvants

Table 7: Bacterial ghosts as candidate vaccines

Table 8: Examples of liposomal veterinary vaccines

Table 9: Summary descriptions of some commonly used adjuvants in vaccines and research

Table 10: Summary characteristics of some bacterial derived adjuvants

Table 11: Summary characteristics of non-bacterially derived adjuvants

Table 12: Aetiological agents of economically important poultry infectious diseases

Table 13: Global systems of poultry production (FAO)

Table 14: Some available Brucella vaccine products

Table 15: Common sheep disease caused by clostridial organisms

Table 16: Vaccines for other enzootic diseases of sheep

Table 17: OIE List Diseases of sheep and goats

Table 18: Some examples of pig diseases that may be controlled by vaccination

Table 19: Examples of multivalent dog vaccines

Table 20: Examples of cat multivalent vaccines

Table 21: Some fish vaccines marketed globally

Table 22: Advantages and disadvantages of vaccine administration via water

Table 23: Methods of DNA vaccine delivery

Table 24: Vaccines registered by EU centralised procedure 2014-2018

For more information about this report visit https://www.researchandmarkets.com/r/5b95ux

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Animal Pharmaceuticals

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Animal Pharmaceuticals